Stifel Maintains Buy on OrthoPediatrics, Raises Price Target to $27
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $24 to $27.
Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $24 to $27.
